Results 341-360 of 1,499 for drugs speaker:Stephen Donnelly

Written Answers — Department of Health: Medicinal Products (23 Feb 2023)

Stephen Donnelly: The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drug schemes, in accordance with the Health (Pricing and Supply of Medical Goods) Act 2013. HSE decisions on which medicines are reimbursed by the taxpayer are made on objective, scientific and economic grounds, on the advice of the National Centre for...

Written Answers — Department of Health: Medicinal Products (23 Feb 2023)

Stephen Donnelly: ...pregnancy, which is expected to affect about 1% of the pregnant population. The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drugs schemes, in accordance with the Health (Pricing and Supply of Medical Good s) Act 2013. I, as the Minister for Health, have no role in these decisions. In line with the...

Written Answers — Department of Health: Medicinal Products (22 Feb 2023)

Stephen Donnelly: ...pregnancy, which is expected to affect about 1% of the pregnant population. The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drugs schemes, in accordance with the Health (Pricing and Supply of Medical Good s) Act 2013. In line with the Act and the national framework agreed with industry, a company...

Written Answers — Department of Health: Medicinal Products (22 Feb 2023)

Stephen Donnelly: ..., which is expected to affect about 1% of the pregnant population. The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drugs schemes, in accordance with the Health (Pricing and Supply of Medical Good s) Act 2013. I, as the Minister for Health, have no role in these decisions. Within the...

Written Answers — Department of Health: Healthcare Policy (22 Feb 2023)

Stephen Donnelly: ...In circumstances where an applicant is still over the income limit for a medical card, they are then assessed for a GP visit card, which entitles the applicant to GP visits without charge. The Drug Payment Scheme (DPS) ensures that no individual or family pays more than €80 a month towards the cost of approved prescribed medicines. The DPS is not means tested and is available to...

Written Answers — Department of Health: Medicinal Products (21 Feb 2023)

Stephen Donnelly: ...pregnancy, which is expected to affect about 1% of the pregnant population. The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drugs schemes, in accordance with the Health (Pricing and Supply of Medical Good s) Act 2013. Only licenced indications which have been granted market authorisation by the...

Written Answers — Department of Health: Medical Cards (21 Feb 2023)

Stephen Donnelly: The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicinal products under the community drug schemes, in accordance with the Health (Pricing and Supply of Medical Goods) Act 2013. Reimbursement for medicines under the community drugs schemes is for licensed indications which have been granted market authorisation by the European...

Ceisteanna - Questions: Medicinal Products (16 Feb 2023)

Stephen Donnelly: ...negotiations in place, which work very well. In fact, the reason we are in this situation is because Cariban is not a licensed product and this means there was no normal mechanism to make this drug freely available. We cannot compel the company to do this. Indeed, we cannot compel any of the other companies, which the Deputy referred to, that have other products which are also seen to...

Ceisteanna ar Reachtaíocht a Gealladh - Questions on Promised Legislation (15 Feb 2023)

Stephen Donnelly: I thank the Deputy and acknowledge his ongoing work on rare diseases and, indeed, on access to orphan drugs. My intention is that the Mazars report will be published along with a view from Government as to the actions that can be taken in light of the report. That will happen shortly before Rare Disease Day.

Written Answers — Department of Health: Medicinal Products (15 Feb 2023)

Stephen Donnelly: ...gravidarum is expected to affect about 1% of the pregnant population. The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drugs schemes, in accordance with the Health (Pricing and Supply of Medical Good s) Act 2013. Only licenced indications which have been granted market authorisation by the European...

Written Answers — Department of Health: Medicinal Products (15 Feb 2023)

Stephen Donnelly: ...gravidarum is expected to affect about 1% of the pregnant population. The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drugs schemes, in accordance with the Health (Pricing and Supply of Medical Good s) Act 2013. Only licenced indications which have been granted market authorisation by the European...

Written Answers — Department of Health: Medicinal Products (15 Feb 2023)

Stephen Donnelly: ...gravidarum is expected to affect about 1% of the pregnant population. The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drugs schemes, in accordance with the Health (Pricing and Supply of Medical Good s) Act 2013. Only licenced indications which have been granted market authorisation by the European...

Written Answers — Department of Health: Medicinal Products (15 Feb 2023)

Stephen Donnelly: The HSE has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drugs schemes, in accordance with the Health (Pricing and Supply of Medical Goods) Act 2013. HSE decisions on which medicines are reimbursed by the taxpayer are made on objective, scientific and economic grounds, on the advice of the National Centre for Pharmacoeconomics (NCPE)....

Written Answers — Department of Health: Medicinal Products (14 Feb 2023)

Stephen Donnelly: ...gravidarum is expected to affect about 1% of the pregnant population. The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drugs schemes, in accordance with the Health (Pricing and Supply of Medical Good s) Act 2013. Only licensed indications which have been granted market authorisation by the European...

Written Answers — Department of Health: Medicinal Products (14 Feb 2023)

Stephen Donnelly: ...gravidarum, a severe form of nausea and vomiting, during pregnancy. The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drugs schemes, in accordance with the Health (Pricing and Supply of Medical Goods) Act 2013. Only licensed indications which have been granted market authorisation by the European...

Written Answers — Department of Health: Medicinal Products (14 Feb 2023)

Stephen Donnelly: ...gravidarum is expected to affect about 1% of the pregnant population. The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drugs schemes, in accordance with the Health (Pricing and Supply of Medical Good s) Act 2013. Only licensed indications which have been granted market authorisation by the European...

Written Answers — Department of Health: Medicinal Products (14 Feb 2023)

Stephen Donnelly: ...gravidarum is expected to affect about 1% of the pregnant population. The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drugs schemes, in accordance with the Health (Pricing and Supply of Medical Good s) Act 2013. Only licensed indications which have been granted market authorisation by the European...

Written Answers — Department of Health: Medicinal Products (14 Feb 2023)

Stephen Donnelly: ...gravidarum is expected to affect about 1% of the pregnant population. The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drugs schemes, in accordance with the Health (Pricing and Supply of Medical Good s) Act 2013. Only licenced indications which have been granted market authorisation by the European...

Written Answers — Department of Health: Medicinal Products (14 Feb 2023)

Stephen Donnelly: ...gravidarum is expected to affect about 1% of the pregnant population. The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drugs schemes, in accordance with the Health (Pricing and Supply of Medical Good s) Act 2013. Only licenced indications which have been granted market authorisation by the European...

Written Answers — Department of Health: Medicinal Products (14 Feb 2023)

Stephen Donnelly: ...gravidarum is expected to affect about 1% of the pregnant population. The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drugs schemes, in accordance with the Health (Pricing and Supply of Medical Good s) Act 2013. Only licenced indications which have been granted market authorisation by the European...